The National Healthcare CMO Summit is bringing together esteemed Chief Medical Officers and industry leaders in Dallas, Texas

Known as the foremost gathering for Chief Medical Officers representing healthcare organizations across the Americas, this exclusive event will take place on 28 – 29 September 2023 at the prestigious Fairmont Grand Del Mar, San Diego, CA, US.

Noteworthy past attendees from the National Healthcare CMO Summit include:

  • Chief Medical Director – Yale New Haven Health System
  • Chief Medical Officer & Vice President – Baptist Health Richmond
  • Chief Medical Officer Southern California – Tenet Healthcare
  • Chief Medical Director – Banner Health
  • Chief Medical Officer – Ascension Texas
  • Chief Medical Officer – Denver Health

The Summit offers a highly effective format of face-to-face business meetings with our esteemed family offices. These meetings are meticulously pre-vetted, pre-scheduled, and mutually agreed upon, ensuring productive one-on-one interactions. We understand the value of time and the importance of forging meaningful connections. That’s why we are committed to delivering an exclusive networking environment that maximizes opportunities for collaboration and strategic partnerships.

Join us at the National Healthcare CMO Summit and experience the benefits of our unparalleled face-to-face meetings. Discover the efficiency, expertise, and exceptional outcomes that have made this format a trusted choice for top industry leaders.

Register your interest today by visiting https://bit.ly/44pja7w or contact Isidora Avraam at isidoraa@marcusevanscy.com.

#mecmosummit

 

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”